Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway
- 27 July 2001
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 20 (33) , 4457-4465
- https://doi.org/10.1038/sj.onc.1204608
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 24 references indexed in Scilit:
- Molecular Cloning and Characterization of a Novel Human Gene Containing Ankyrin Repeat and Double BTB/POZ DomainBiochemical and Biophysical Research Communications, 2000
- EB3, a novel member of the EB1 family preferentially expressed in the central nervous system, binds to a CNS-specific APC homologueOncogene, 2000
- APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesisOncogene, 1999
- Mutation of thePTENTumor Suppressor Gene Is Not a Feature of Ovarian CancersGynecologic Oncology, 1998
- Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formationInternational Journal of Cancer, 1997
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- The Transcription Factors SCIP and Krox-20 Mark Distinct Stages and Cell Fates in Schwann Cell DifferentiationMolecular and Cellular Neuroscience, 1996
- Krox-20 controls myelination in the peripheral nervous systemNature, 1994
- The POZ domain: a conserved protein-protein interaction motif.Genes & Development, 1994